Clinical Trials
26
Active:1
Completed:3
Trial Phases
4 Phases
Early Phase 1:3
Phase 1:4
Phase 2:2
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (23 trials with phase data)• Click on a phase to view related trials
Not Applicable
14 (60.9%)Phase 1
4 (17.4%)Early Phase 1
3 (13.0%)Phase 2
2 (8.7%)Insulin-sensitizing NE3107 in Improving Sleep and Fatigue in Subjects With Traumatic Brain Injury
- First Posted Date
- 2023-08-01
- Last Posted Date
- 2024-07-17
- Lead Sponsor
- Neurological Associates of West Los Angeles
- Target Recruit Count
- 5
- Registration Number
- NCT05970575
- Locations
- 🇺🇸
The Regenesis Project, Santa Monica, California, United States
Open Label Study for the Use of Transcranial Ultrasound Treatment of Tremor
Early Phase 1
Recruiting
- Conditions
- Parkinson DiseaseEssential TremorTremor
- First Posted Date
- 2022-07-26
- Last Posted Date
- 2023-01-26
- Lead Sponsor
- Neurological Associates of West Los Angeles
- Target Recruit Count
- 50
- Registration Number
- NCT05475340
- Locations
- 🇺🇸
Neurological Associates of West Los Angeles, Los Angeles, California, United States
Insulin-Sensitizing Anti-Inflammatory Small Molecule for Investigative Treatment of Dementia
- First Posted Date
- 2022-02-07
- Last Posted Date
- 2024-07-09
- Lead Sponsor
- Neurological Associates of West Los Angeles
- Target Recruit Count
- 23
- Registration Number
- NCT05227820
- Locations
- 🇺🇸
Neurological Associates - The Interventional Group, Santa Monica, California, United States
Plasmapheresis for Treatment of Age-Related Frailty
Early Phase 1
- Conditions
- Age-Related Frailty
- First Posted Date
- 2021-09-23
- Last Posted Date
- 2022-04-18
- Lead Sponsor
- Neurological Associates of West Los Angeles
- Target Recruit Count
- 100
- Registration Number
- NCT05054894
- Locations
- 🇺🇸
Neurological Associates - The Interventional Group, Santa Monica, California, United States
Omega 3 Oil: Aging-Related Cognitive Decline
Phase 1
- Conditions
- Aging Related Cognitive Decline
- First Posted Date
- 2021-09-10
- Last Posted Date
- 2022-07-22
- Lead Sponsor
- Neurological Associates of West Los Angeles
- Target Recruit Count
- 40
- Registration Number
- NCT05041088
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- Next
News
No news found